Recent Comments

Comment RSS

Anesthetics News and Research RSS Feed - Anesthetics News and Research

Neurometrix reports financial results for the third quarter of 2009

5. November 2009 07:32
NeuroMetrix, Inc., a health care company transforming patient care through neurotechnology, today announced its third quarter financial results. [More]

Posted in: Business / Finance

Tags: , , , , , , ,

Financial results for third-quarter 2009 announced by Combinatorx

3. November 2009 08:47
CombinatoRx, Incorporated today reported financial results for the third quarter ended September 30, 2009. [More]

Study: General anesthesia can cause brain injury in immature rats

23. October 2009 02:42
Studies by researchers at Wake Forest University School of Medicine have shown that blocking the NMDA receptor in immature rats leads to profound, rapid brain injury and disruption of auditory function as the animals mature. [More]

Positive results from Phase 2 clinical trial of ARX-03 announced

23. October 2009 00:10
AcelRx Pharmaceuticals, Inc. today announced positive results from a Phase 2 clinical trial of ARX-03, a proprietary sublingual dosage form combining an opioid, sufentanil, with a benzodiazepine, triazolam. [More]

Posted in: Drug Trial News

Tags: , , ,

GE Healthcare announces FDA clearance of CARESCAPE Monitor B850

6. October 2009 00:15
GE Healthcare today announced the FDA-cleared CARESCAPE™ Monitor B850, which provides caregivers with a unique level of integration between patient monitoring data and hospital information systems. Unlike traditional patient monitors, CARESCAPE Monitor B850 directly links hospital networks, electronic medical records (EMRs), diagnostic images, lab results and third-party devices with real-time patient monitoring data, to support efficient clinical decision-making. [More]

Posted in: Device / Technology News

Tags: , ,

Covidien receives 510(k) clearance to market Mallinckrodt Taperguard Evac endotracheal tube

1. October 2009 05:21
Covidien, a leading global provider of healthcare products and recognized innovator in mechanical ventilation and respiratory care devices, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its Mallinckrodt™ TaperGuard™ Evac endotracheal tube. [More]

Posted in: Device / Technology News

Tags: , ,

Covidien to acquire Aspect Medical Systems

28. September 2009 07:37
Covidien (NYSE: COV) and Aspect Medical Systems, Inc. (NASDAQ: ASPM) today announced that Covidien has reached a definitive agreement to acquire Aspect, a global market leader in brain monitoring technology. [More]

Posted in: Business / Finance

Tags: ,

Research study sheds light on mechanisms of pain alteration in infancy and adolescence

26. September 2009 00:05
Scientists at Georgia State University have uncovered the mechanisms of how pain in infancy alters how the brain processes pain in adulthood. [More]

NASDAQ halts trading in CombinatoRx's common stock

23. September 2009 07:53
CombinatoRx, Incorporated (NASDAQ: CRXX) announced that NASDAQ has halted trading in the Company’s common stock today. [More]

Posted in: Business / Finance

Tags: , ,

FDA committees to review Neuromed’s NDA for Exalgo

23. September 2009 03:02
CombinatoRx, Incorporated (NASDAQ: CRXX) and Neuromed Pharmaceuticals, Inc., a privately-held biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has posted on its website briefing documents for the September 23, 2009 joint meeting of its Anesthetics and Life Support Advisory Committee and its Drug Safety and Risk Management Advisory Committee. [More]

Posted in: Pharmaceutical News

Tags: , , , , ,

King Pharmaceuticals achieves milestone: Announces commercial availability of EMBEDA

21. September 2009 07:55
King Pharmaceuticals(R), Inc. (NYSE: KG) today announced a true milestone as it marks the first commercial availability for EMBEDA(TM) (morphine sulfate and naltrexone hydrochloride) Extended Release Capsules, a long-acting Schedule II opioid analgesic for the management of moderate to severe pain when a continuous, around-the-clock opioid analgesic is needed for an extended period of time. [More]

Principles and Practices of Pain Medicine training program from Research and Markets

14. September 2009 05:08
Research and Markets has announced the addition of the "Principles and Practices of Pain Medicine" training to their offering. [More]

Wisconsin researchers identify the genetic region responsible for cardiovascular collapse during anesthesia

11. September 2009 07:56
Researchers at The Medical College of Wisconsin in Milwaukee have identified the genetic region in rats responsible for cardiovascular collapse during anesthesia. While it is well known that people have different cardiovascular sensitivity to anesthesia causing some to collapse even when low doses are administered, the mechanism responsible for this susceptibility is not clear. [More]

Forecast of the size of the global dental equipment and consumables market

11. September 2009 05:10
The dental devices report forecasts the size of global dental equipment and consumables market over the period 2009 – 2014. The report analyses the key trends of the market, and segments the global dental equipment and consumables market by components and into various geographic regions (with the market size for each of these regions). [More]

NeuroMetrix completes private placement of common stock and warrants

11. September 2009 00:25
NeuroMetrix, Inc., today announced that it has completed its private placement of common stock and warrants. Gross proceeds from the offering were approximately $18.7 million. [More]

Posted in: Business / Finance

Tags: , , , , ,

News-Medical.Net provides this medical information service in accordance with these terms and conditions. Please note that medical information found on this website is designed to support, not to replace the relationship between patient and physician/doctor and the medical advice they may provide.